Search Results for: LYN

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CD79A CD79a molecule
  • CD22 mediated BCR regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Agammaglobulinemias, including the following six diseases: X-linked agammaglobulinemia (Bruton's agammaglobulinemia, XLA); IgM heavy chain gene deletions; Ig-alpha defect; Autosomal recessive agammaglobulinaemia; B cell-linker protein (BLNK) deficiency; Leucine-rich repeat-containing 8
CD79B CD79b molecule
  • CD22 mediated BCR regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Polatuzumab vedotin
  • Agammaglobulinemias, including the following six diseases: X-linked agammaglobulinemia (Bruton's agammaglobulinemia, XLA); IgM heavy chain gene deletions; Ig-alpha defect; Autosomal recessive agammaglobulinaemia; B cell-linker protein (BLNK) deficiency; Leucine-rich repeat-containing 8
FOLR1 folate receptor alpha
  • COPII-mediated vesicle transport
  • Cargo concentration in the ER
  • COPI-mediated anterograde transport
  • Folic acid
  • Vintafolide
  • Farletuzumab
GP6 glycoprotein VI platelet
  • GPVI-mediated activation cascade
  • Cell surface interactions at the vascular wall
  • Platelet Adhesion to exposed collagen
NMT1 N-myristoyltransferase 1
  • Late Phase of HIV Life Cycle
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Activation, myristolyation of BID and translocation to mitochondria
  • (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone
PTK2B protein tyrosine kinase 2 beta
  • Signal regulatory protein family interactions
  • VEGFA-VEGFR2 Pathway
  • Interleukin-2 signaling
  • Leflunomide
  • Genistein
  • 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide
  • Baricitinib
  • Fostamatinib
PTPRC protein tyrosine phosphatase receptor type C
  • Phosphorylation of CD3 and TCR zeta chains
  • Other semaphorin interactions
  • Neutrophil degranulation
  • T-B+Severe combined immunodeficiencies (SCIDs), including the following eight diseases: X-linked SCID; Janus kinase-3 (Jak3) deficiency; IL-7 receptor alpha (IL7R alpha) deficiency; IL-2 receptor alpha (IL2R alpha) deficiency; CD45 deficiency; CD3 deficiency; Winged Helix Nude (WHN) deficiency; Immunodeficiency with thynoma
TRIM28 tripartite motif containing 28
  • Generic Transcription Pathway
  • SUMOylation of transcription cofactors
  • HCMV Early Events
ADAM15 ADAM metallopeptidase domain 15
  • Degradation of the extracellular matrix
  • Invadopodia formation
CSF1R colony stimulating factor 1 receptor
  • Other interleukin signaling
  • Transcriptional Regulation by VENTX
  • Imatinib
  • Sunitinib
  • ABT-869
  • 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE
  • 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE
  • Fostamatinib
  • Erdafitinib
  • Pexidartinib
  • Choriocarcinoma
CSF3R colony stimulating factor 3 receptor
  • Other interleukin signaling
  • Transcriptional regulation of granulopoiesis
  • Pegfilgrastim
  • Filgrastim
  • FavId
  • Lenograstim
  • Lipegfilgrastim
CTLA4 cytotoxic T-lymphocyte associated protein 4
  • CTLA4 inhibitory signaling
  • RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
  • Ipilimumab
  • Tremelimumab
  • Type I diabetes mellitus
  • Graves' disease
  • Allograft rejection
  • Hashimoto's thyroiditis
DOK1 docking protein 1
  • PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
  • RET signaling
DOK2 docking protein 2
  • Tie2 Signaling
  • RET signaling
MME membrane metalloendopeptidase
  • Metabolism of Angiotensinogen to Angiotensins
  • Neutrophil degranulation
  • Candoxatril
  • Omapatrilat
  • N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine
  • Phosphoramidon
  • N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine
  • [2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala
  • Daglutril
  • 2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM
  • Thiorphan
  • Sacubitril
  • Candoxatrilat
NPHS1 NPHS1 adhesion molecule, nephrin
  • Nephrin family interactions
  • Nephrin family interactions
  • Nephrotic syndrome and focal segmental glomerulosclerosis
PAG1 phosphoprotein membrane anchor with glycosphingolipid microdomains 1
  • GAB1 signalosome
  • Phosphorylation of CD3 and TCR zeta chains
PDE4A phosphodiesterase 4A
  • DARPP-32 events
  • G alpha (s) signalling events
  • Caffeine
  • Theophylline
  • Dyphylline
  • Enprofylline
  • Dipyridamole
  • Iloprost
  • Oxtriphylline
  • Amrinone
  • Roflumilast
  • Piclamilast
  • Crisaborole
  • Ibudilast
  • Propentofylline
  • Drotaverine
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Tofisopam
  • Trapidil
PDE4D phosphodiesterase 4D
  • DARPP-32 events
  • G alpha (s) signalling events
  • Adenosine phosphate
  • Caffeine
  • Caffeine
  • Dyphylline
  • Iloprost
  • Amrinone
  • Roflumilast
  • Piclamilast
  • Rolipram
  • 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
  • Zardaverine
  • 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • (S)-Rolipram
  • Cilomilast
  • (R)-Rolipram
  • 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • Crisaborole
  • Ibudilast
  • Tetomilast
  • Exisulind
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
  • 3-isobutyl-1-methyl-7H-xanthine
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Trapidil
PPP1R15A protein phosphatase 1 regulatory subunit 15A
  • Downregulation of TGF-beta receptor signaling
  • Response of EIF2AK1 (HRI) to heme deficiency

Page 5 out of 7 pages